ADGRE2 and gallbladder carcinoma: In some tumor entities, such as colorectal, gastric, and gall bladder carcinomas, CD97 is enhanced in tumor buds and/or in cells at the tumor cell margin compared with cells in the tumor center, further indicating a key role of CD97 in invasion [32,67,72] (Figure 2c).